“EVER Neuro Pharma is an Austrian pharmaceutical company focused on the field of neuroscience. Based on our experience and proprietary R&D technology platform we develop innovative therapies for neurodegenerative and cerebrovascular disorders.
At the core of our technologically mature and safe products portfolio is Cerebrolysin, a neurotrophic peptide compound which mimics the actions of endogenous neurotrophic factors.
“EVER Neuro Pharma is an Austrian pharmaceutical company focused on the field of neuroscience. Based on our experience and proprietary R&D technology platform we develop innovative therapies for neurodegenerative and cerebrovascular disorders.
At the core of our technologically mature and safe products portfolio is Cerebrolysin, a neurotrophic peptide compound which mimics the actions of endogenous neurotrophic factors.
The future development of therapies for neurological diseases will increasingly relay on the pleiotropic, multifunctional approach. Recognizing this trend we keep to our endeavor for further refinement of the neurotrophic therapies, and for constant improvement of our patient oriented services.
We also recognize and respond to the growing need for innovative treatments related to the aging global population, including the unmet therapeutic needs for rare neurological disorders.”
